Mereo BioPharma (MREO) Other Working Capital Changes (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Other Working Capital Changes of -$201000.0 for Q1 2026, down 18.24% year-on-year from -$245827.3 in Q1 2025, and down 3.61% on a QoQ basis from -$194000.0 in Q4 2025.
Mereo BioPharma (MREO) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Other Working Capital Changes for 4 consecutive years, with -$201000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Working Capital Changes fell 18.24% year-over-year to -$201000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$774000.0 (down 15.87% YoY) and the FY2025 annual result came in at -$743000.0, down 13.61% from the prior year.
- Other Working Capital Changes eased to -$201000.0 in Q1 2026 per MREO's latest filing, from -$194000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for MREO reached as high as $9.4 million in Q2 2023 and fell as low as -$8.5 million in Q3 2023.
- A 4-year average of -$282230.8 and a median of -$235000.0 in 2025 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 8.97% in 2025 against a maximum downside of 19.38% in 2025.
- Year by year, Other Working Capital Changes stood at -$150000.0 in 2023, then decreased by 13.33% to -$170000.0 in 2024, then dropped by 14.12% to -$194000.0 in 2025, then retreated by 3.61% to -$201000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$201000.0, -$194000.0, and -$188000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Jun 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -191,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Dec 31, 2024 | -170,000.00 |
| Dec 31, 2024 | -170,000.00 |
| Dec 31, 2024 | -170,000.00 |
| Sep 30, 2024 | -168,000.00 |
| Sep 30, 2024 | -168,000.00 |